CM Life Sciences II To Combine With Proteomics SomaLogic In Latest SPAC Deal

 
• By Marion Webb

The SPAC deal between CM Life Sciences II and SomaLogic is valued at $1.25bn.

SPAC

More from Financing

More from Business